Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...

Quantum-Si incorporated (NASDAQ:QSI) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Doug Farrell - VP, IR Jeffrey Hawkins - President & CEO Jeffry Keyes - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Operator Good day, and thank you for standing by. Welcome to the 2024 Third Quarter Quantum-Si Earnings Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator I ...

Revenue and Profit Growth - Total revenue increased by $0.6 million (252.9%) for the three months and $1.2 million (173.6%) for the nine months ended September 30, 2024, compared to the same periods in 2023[125][128] - Gross profit increased by $0.3 million (239.8%) for the three months and $0.7 million (219.4%) for the nine months ended September 30, 2024, compared to the same periods in 2023[125][128][129] - The company's Platinum instrument and related reagent kits and service maintenance contracts drove the increase in revenue[128] Cost and Expense Changes - Cost of revenue increased by $0.3 million (265.2%) for the three months and $0.5 million (135.5%) for the nine months ended September 30, 2024, compared to the same periods in 2023[125][128] - Research and development expenses decreased by $0.4 million (2.5%) for the three months and $7.9 million (15.7%) for the nine months ended September 30, 2024, compared to the same periods in 2023[125][131][132] - Selling, general and administrative expenses increased by $1.6 million (14.8%) for the three months and $3.2 million (9.8%) for the nine months ended September 30, 2024, compared to the same periods in 2023[125] - Selling, general and administrative expenses increased by $1.6 million (14.8%) for the three months ended September 30, 2024, primarily due to higher stock-based compensation and payroll costs[134] - Selling, general and administrative expenses increased by $3.2 million (9.8%) for the nine months ended September 30, 2024, driven by higher payroll, outsourced services, and marketing expenses[135] Net Loss and Financial Performance - Net loss decreased by $0.6 million (2.4%) for the three months and $6.0 million (8.2%) for the nine months ended September 30, 2024, compared to the same periods in 2023[125] - Dividend and interest income increased by $0.1 million (4.5%) and $1.9 million (25.8%) for the three and nine months ended September 30, 2024, respectively, due to higher earnings from marketable securities[137] - Unrealized gain on trading securities was $0 for the three and nine months ended September 30, 2024, compared to gains of $2.0 million and $8.3 million in the same periods of 2023[139] - Realized loss on trading securities was $0 for the three and nine months ended September 30, 2024, compared to losses of $1.9 million and $6.5 million in the same periods of 2023[140] - Change in fair value of warrant liabilities decreased by $0.1 million for the three months ended September 30, 2024, and decreased by $0.9 million for the nine months ended September 30, 2024[142] Cash Flow and Investments - Net cash used in operating activities was $64.9 million for the nine months ended September 30, 2024, primarily due to a net loss of $67.9 million and R&D spending[146] - Net cash used in investing activities was $26.8 million for the nine months ended September 30, 2024, compared to net cash provided by investing activities of $82.4 million in the same period of 2023[148] - The company had cash and cash equivalents and investments in marketable securities totaling $196.3 million as of September 30, 2024[152] - Marketable securities as of September 30, 2024, primarily consist of U.S. government-backed money market funds, Treasury bills, and high-quality corporate commercial paper, with minimal expected impact from interest rate changes[161] Lease and Licensing Commitments - Future lease payments under non-cancellable lease agreements were approximately $27.8 million as of September 30, 2024[156] - Annual minimum fixed payments for intellectual property licenses total approximately $0.1 million, with additional royalties based on net sales if they exceed the fixed payments[157] Business and Market Expansion - The company initiated a full commercial launch of the Platinum instrument at the end of the first quarter of 2024[123][129] - The company's platform is designed to streamline sequencing and data analysis at a lower instrument cost than legacy proteomic solutions[123] - The company's platform could be used for biomarker discovery, disease detection, pathway analysis, immune response, vaccine development, and quality assurance[123] - The company anticipates future expansion into Europe and other regions, which may increase foreign currency risk, though no hedging arrangements are currently in place[162][163] Financial and Operational Risks - The company's financial statements are prepared based on estimates and assumptions, which may differ under different conditions, impacting reported assets, liabilities, and expenses[158] - Inflation has impacted the cost of supplies and manufacturing components, potentially affecting the company's ability to offset higher costs through price increases or efficiencies[160]

Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this company would post a loss of $0.21 per share when it actually produced a loss of $0.16, delivering a surprise of 23.81%.Over the last four quarters, the company has s ...

Exhibit 99.1 QUANTUM SI Quantum-Si Reports Third Quarter 2024 Financial Results Sales Pipeline is Accelerating and New Kits Remain on Track for Q4 Launch BRANFORD, Conn. -- (BUSINESS WIRE) -- November 12, 2024 -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the third quarter ended September 30, 2024. Press Release Highlights • Reported revenue of $787,000 for the third quarter of 2024 • Announced that Lib ...

Investors might want to bet on Quantum-Si Incorporated (QSI) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate. Since a ...

Quantum-Si incorporated (NASDAQ:QSI) Q2 2024 Earnings Call Transcript August 7, 2024 4:30 PM ET Company Participants Doug Farrell - VP, IR Jeff Hawkins - President and CEO Jeff Keyes - CFO Conference Call Participants Swayampakula Ramakanth - HCW Operator Ladies and gentlemen, thank you for standing by. Welcome to the Quantum-Si's Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operat ...

Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 23.81%. A quarter ago, it was expected that this company would post a loss of $0.23 per share when it actually produced a loss of $0.14, delivering a surprise of 39.13%. Over the last four quarters, the company has ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________ Title of each class Trading Symbol(s) Name of each exchange on which registered Class A common stock, $0.0001 per share QSI The Nasdaq Stock Market LLC Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share QSIAW The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SEC ...

Revenue and Profit - Reported revenue of $622,000 in the second quarter of 2024[2] - Gross profit of $354,000 with a gross margin of 57% in Q2 2024[3] - Total revenue for Q2 2024 increased to $622K, up 203% from $205K in Q2 2023[14] - Gross profit for Q2 2024 rose to $354K, a 354% increase from $78K in Q2 2023[14] Operating Expenses - Total operating expenses of $26.8 million in Q2 2024, compared to $27.0 million in the prior year[3] - Adjusted total operating expenses of $24.4 million in Q2 2024, compared to $24.0 million in the prior year[3] - Research and development expenses for Q2 2024 decreased to $14,381K from $15,834K in Q2 2023[14] - Selling, general and administrative expenses for Q2 2024 increased to $12,424K from $11,136K in Q2 2023[14] - Adjusted total operating expenses for Q2 2024 were $24,374K, compared to $24,038K in Q2 2023[16] Net Loss and Adjusted EBITDA - Net loss of $23.1 million in Q2 2024, compared to a net loss of $25.6 million in the prior year[3] - Adjusted EBITDA of negative $22.6 million in Q2 2024, compared to negative $22.9 million in the prior year[3] - Net loss for Q2 2024 improved to $(23,099)K, compared to $(25,573)K in Q2 2023[14] - Adjusted EBITDA for Q2 2024 was $(22,633)K, slightly better than $(22,870)K in Q2 2023[15] Cash and Investments - Cash and cash equivalents and investments in marketable securities totaled $218.1 million as of June 30, 2024[4] - Dividend and interest income for Q2 2024 was $2,887K, up from $2,483K in Q2 2023[14] Product Launches and Development - Expects to launch a version 2 library prep kit and a barcoding application specific library prep kit by the end of 2024[2] - Announced the launch of the version 3 sequencing kit[2] - Completed the first quarter of full commercial launch of the Platinum instrument in Q2 2024[2] Other Financial Metrics - Stock-based compensation for Q2 2024 was $2,400K, compared to $1,865K in Q2 2023[15] - Restructuring costs for Q2 2024 were $31K, down from $1,067K in Q2 2023[15]